An Update from UK CLL "Superstar" Dr. George F... - CLL Support

CLL Support

22,367 members38,474 posts

An Update from UK CLL "Superstar" Dr. George Follows

andrewschorr profile image
3 Replies

Dear CLL friends:

One of my favorite CLL “teachers” is Dr. George Follows from Cambridge University in the UK. Here’s what he told us about the latest in CLL from the ASH meeting recently.

patientpower.eu/videos/dr-g...

Also, stay tuned for details on the upcoming Patient Power in-person and online CLL town meeting from Phoenix, Arizona on March 29th where patients and family members can ask plenty of questions of THREE experts. I look forward to seeing you there if you enjoy the sun, Spring training baseball and hate the snow in the Northeastern US! Best Wishes, Andrew Schorr

Written by
andrewschorr profile image
andrewschorr
To view profiles and participate in discussions please or .
3 Replies
SBMACLL profile image
SBMACLL

Dear Andrew,

Thank you for posting the interview.

Best regards,

Steve

HAIRBEAR_UK profile image
HAIRBEAR_UKFounder Admin

Great interview and video, many thanks

Nick

ballyhoo profile image
ballyhoo

Thank you Andrew and patientpower.

Your video's are very encouraging and helpful. Bless you

You may also like...

Dr George Follows and your CLL questions

about CLL and news for patients: Drs. Jeff Sharman, Phil Thompson, Tom Kipps (invited) and George...

UK Zoom meeting - COVID-19 and shielding update for UK CLL Patients

Marc Auckland, Chair of Trustees at CLL Support and a CLL patient plus a member of this HU...

Dr Michael Keating's Story - Taking CLL Therapies From Bedside to Community

cure. From humble beginnings in Melbourne Australia, to a fulfilling career at the forefront of...

UK CLL Forum - updated post lockdown guidance for the management of CLL

the COVID19 pandemic the UK CLL Forum issued guidance on managing CLL patients. This guidance has...

My 1 year CAR-T anniversary and from ASH 2018, Dr. Siddiqi on how CLL treatment has changed.

changing data that emerged from ASH 2018. See:...